Cargando…
Targeted therapies for previously treated advanced or metastatic renal cell carcinoma: systematic review and network meta-analysis
OBJECTIVE: To compare the effectiveness and safety of treatments for advanced or metastatic renal cell carcinoma (amRCC) after treatment with vascular endothelial growth factor (VEGF)-targeted treatment. DESIGN: Systematic review and network meta-analysis of randomised controlled trials (RCTs) and c...
Autores principales: | Karner, Charlotta, Kew, Kayleigh, Wakefield, Victoria, Masento, Natalie, Edwards, Steven J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429896/ https://www.ncbi.nlm.nih.gov/pubmed/30826762 http://dx.doi.org/10.1136/bmjopen-2018-024691 |
Ejemplares similares
-
Network Meta-Analysis of Once Weekly Selinexor-Bortezomib-Dexamethasone in Previously Treated Multiple Myeloma
por: Dolph, Michael, et al.
Publicado: (2021) -
Metastatic Vascular Pleomorphic Leiomyosarcoma in a Previously Treated Cervical Carcinoma Patient: A Diagnostic Dilemma
por: Ghani, Umar Hakimin M, et al.
Publicado: (2021) -
Case Report: Low-Dose Decitabine Plus Anti-PD-1 Inhibitor Camrelizumab for Previously Treated Advanced Metastatic Non-Small Cell Lung Cancer
por: Yan, Xin, et al.
Publicado: (2020) -
Anlotinib for Patients With Metastatic Renal Cell Carcinoma Previously Treated With One Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor: A Phase 2 Trial
por: Ma, Jianhui, et al.
Publicado: (2020) -
Metastatic atypical renal tumour with metanephric characteristics treated with Sunitinib
por: Mohammad, H., et al.
Publicado: (2021)